title: Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
authors.affiliation: Department of Pharmacy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA; Emergency Medical Associates, Parsippany, NJ, USA.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Utkewicz
authors.affiliation: Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, New Brunswick, NJ, USA; Department of Pharmacy, Robert Wood Johnson University Hospital Somerset, Somerville, NJ, USA.
authors.forename: Luigi
authors.initials: L
authors.lastname: Brunetti
authors.affiliation: Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, New Brunswick, NJ, USA; Department of Pharmacy, Robert Wood Johnson University Hospital Somerset, Somerville, NJ, USA. Electronic address: nadia.awad@rwjuh.edu.
authors.forename: Nadia I
authors.initials: NI
authors.lastname: Awad
mesh_terms: D000287:Administration, Topical; D000369:Aged, 80 and over; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D004844:Epistaxis / Q000139:chemically induced* / Q000188:drug therapy*; D065427:Factor Xa Inhibitors / Q000009:adverse effects*; D006801:Humans; D008297:Male; D000069552:Rivaroxaban / Q000009:adverse effects*; D014148:Tranexamic Acid / Q000627:therapeutic use*
chemical_list: D000933:Antifibrinolytic Agents; D065427:Factor Xa Inhibitors; D014148:Tranexamic Acid; D000069552:Rivaroxaban